Andrew Witty
GSK’s former chief Witty makes surprise move to ‘the dark side’
Andrew McConaghie
Andrew Witty, GSK
0 Comment
GlaxoSmithKline’s former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.
Healthcare/ R&D/ UK & Europe/ Views and analysis
A new fast track for NHS access – good news for niche innovators
Andrew McConaghie
Accelerated Access Collaborative, Accelerated Access Pathway, Andrew Witty, NHS, pharma innovation
0 Comment
Brexit/ News/ Pharma Market Access/ UK & Europe
EU unimpressed by May’s Brexit plans – but Witty commends ‘edge’
Andrew McConaghie
Andrew Witty, Davos, EU, Guy Verhofstadt
0 Comment